Georgios Kokolakis

1.5k total citations
52 papers, 1.0k citations indexed

About

Georgios Kokolakis is a scholar working on Dermatology, Immunology and Surgery. According to data from OpenAlex, Georgios Kokolakis has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Dermatology, 28 papers in Immunology and 10 papers in Surgery. Recurrent topics in Georgios Kokolakis's work include Psoriasis: Treatment and Pathogenesis (27 papers), Dermatology and Skin Diseases (18 papers) and Hidradenitis Suppurativa and Treatments (12 papers). Georgios Kokolakis is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (27 papers), Dermatology and Skin Diseases (18 papers) and Hidradenitis Suppurativa and Treatments (12 papers). Georgios Kokolakis collaborates with scholars based in Germany, United States and Greece. Georgios Kokolakis's co-authors include Robert Sabat, Kerstin Wolk, Sandra Philipp, Wolfram Sterry, Sylke Schneider‐Burrus, Katrin Witte, Ellen Witte, Katarzyna Warszawska, Hans‐Dieter Volk and Sabine Krüger‐Krasagakis and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Georgios Kokolakis

43 papers receiving 1.0k citations

Peers

Georgios Kokolakis
Stanley Cheuk Sweden
Vesna Petronic‐Rosic United States
Katarzyna Grys United Kingdom
Hyun Je Kim South Korea
Frank Altznauer Switzerland
T.J. Stoof Netherlands
Maria Vittoria Cannizzaro Italy
Catherine H. Orteu United Kingdom
V. Huguier France
Jack Longley United States
Stanley Cheuk Sweden
Georgios Kokolakis
Citations per year, relative to Georgios Kokolakis Georgios Kokolakis (= 1×) peers Stanley Cheuk

Countries citing papers authored by Georgios Kokolakis

Since Specialization
Citations

This map shows the geographic impact of Georgios Kokolakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgios Kokolakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgios Kokolakis more than expected).

Fields of papers citing papers by Georgios Kokolakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgios Kokolakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgios Kokolakis. The network helps show where Georgios Kokolakis may publish in the future.

Co-authorship network of co-authors of Georgios Kokolakis

This figure shows the co-authorship network connecting the top 25 collaborators of Georgios Kokolakis. A scholar is included among the top collaborators of Georgios Kokolakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgios Kokolakis. Georgios Kokolakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spitzer, Carsten, Ines Buchholz, Katharina Meier, et al.. (2025). Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach. Acta Dermato Venereologica. 105. adv42794–adv42794.
2.
Spitzer, Carsten, Katharina Meier, Georgios Kokolakis, et al.. (2025). Facets of shame and their impact on quality of life in patients with atopic dermatitis and psoriasis. Scientific Reports. 15(1). 13753–13753.
3.
Wolk, Kerstin, Dagmar Wilsmann‐Theis, Nessr Abu Rached, et al.. (2025). Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in Germany. Dermatology and Therapy. 15(12). 3651–3670.
4.
Gottlieb, Alice B., Bruce Strober, Georgios Kokolakis, et al.. (2024). 51856 Spesolimab rapidly improves quality of life in patients with generalized pustular psoriasis, as per Dermatology Life Quality Index scores: Data from the Effisayil 2 trial. Journal of the American Academy of Dermatology. 91(3). AB316–AB316. 1 indexed citations
5.
Kokolakis, Georgios, Mark Lebwohl, Peter Foley, et al.. (2024). AB0490 BIMEKIZUMAB EFFICACY THROUGH 3 YEARS IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: LONG-TERM POOLED ANALYSIS FROM BE BRIGHT. Annals of the Rheumatic Diseases. 83. 1513–1513.
6.
Warren, Richard B., David Burden, Siew Eng Choon, et al.. (2023). Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial. SKIN The Journal of Cutaneous Medicine. 7(6). s245–s245. 2 indexed citations
7.
Crowley, Jeffrey, Chih-ho Hong, Melinda Gooderham, et al.. (2023). 44102 Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments. Journal of the American Academy of Dermatology. 89(3). AB82–AB82. 1 indexed citations
8.
9.
Witte, Katrin, et al.. (2023). Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy. Nutrients. 15(17). 3797–3797. 7 indexed citations
10.
Philipp, Sandra, Georgios Kokolakis, Pavel Kolkhir, et al.. (2022). A comprehensive, tri‐national, cross‐sectional analysis of characteristics and impact of pruritus in psoriasis. Journal of the European Academy of Dermatology and Venereology. 36(11). 2064–2075. 10 indexed citations
11.
Weller, Karsten, Robert Sabat, Sandra Philipp, et al.. (2022). Prevalence and factors associated with sleep disturbance in adult patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 36(5). 688–697. 21 indexed citations
12.
Kokolakis, Georgios, Richard B. Warren, Bruce Strober, et al.. (2022). Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. British Journal of Dermatology. 188(3). 330–340. 18 indexed citations
13.
Kokolakis, Georgios, et al.. (2022). Follow-Up Comparison of Fluorescence Optical Imaging With Musculoskeletal Ultrasound for Early Detection of Psoriatic Arthritis. Frontiers in Medicine. 9. 845545–845545. 7 indexed citations
14.
Kokolakis, Georgios, Robert Sabat, Imma Fischer, et al.. (2021). The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice. Journal of Personalized Medicine. 11(11). 1083–1083. 1 indexed citations
15.
Bonnekoh, Hanna, et al.. (2020). Spectrum of Genetic Autoinflammatory Diseases Presenting with Cutaneous Symptoms. Acta Dermato Venereologica. 100(7). adv00091–151. 9 indexed citations
16.
Witte, Katrin, Karsten Jürchott, Jochen Hecht, et al.. (2019). Increased presence and differential molecular imprinting of transit amplifying cells in psoriasis. Journal of Molecular Medicine. 98(1). 111–122. 8 indexed citations
17.
Hofmann, Maja A. & Georgios Kokolakis. (2017). A case report of combination treatment with potassium-titanyl phosphate laser and brimonidine topical gel in erythematotelangiectatic rosacea. Journal of Cosmetic and Laser Therapy. 19(4). 222–224. 6 indexed citations
18.
Witte, Ellen, Georgios Kokolakis, Katrin Witte, et al.. (2014). IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis. Journal of Investigative Dermatology. 134(11). 2757–2767. 136 indexed citations
19.
Wolk, Kerstin, Katrin Witte, Ellen Witte, et al.. (2013). IL-29 Is Produced by T H 17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis. Science Translational Medicine. 5(204). 204ra129–204ra129. 108 indexed citations
20.
Kokolakis, Georgios, et al.. (2008). From the protein to the graph: How to quantify immunohistochemistry staining of the skin using digital imaging. Journal of Immunological Methods. 331(1-2). 140–146. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanley Cheuk Breakdown of academic impact, for papers by Vesna Petronic‐Rosic Breakdown of academic impact, for papers by Katarzyna Grys Breakdown of academic impact, for papers by Hyun Je Kim Breakdown of academic impact, for papers by Frank Altznauer Breakdown of academic impact, for papers by T.J. Stoof Breakdown of academic impact, for papers by Maria Vittoria Cannizzaro Breakdown of academic impact, for papers by Catherine H. Orteu Breakdown of academic impact, for papers by V. Huguier Breakdown of academic impact, for papers by Jack Longley
Rankless by CCL
2026